Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Titan Biotech Ltd (TITANBIO) Share Price & Fundamentals

Company Overview

Founded Year

-

Listed Year

-

Headquarter

New Delhi, India

MD/CEO

-

Website

https://titanbiotechltd.com

Company Facts

What we do

Titan Biotech Ltd manufactures biological peptones, extracts, and dehydrated culture media supporting microbiological growth in pharmaceutical, clinical, and research sectors.

Founded in

-

Market share

A reputed manufacturer catering to domestic and international markets with growing exports and modernization to meet global standards.

Problem solved

Provides essential culture media and biological products vital for microbiology research, vaccine production, antibiotic testing, and contamination control.

Top clients or who we serve

Pharmaceutical companies, clinical labs, research institutes, universities, food and water safety labs; B2B focus.

Key management

-

Our journey and innovations

Introduced gamma radiation culture media and lab chemicals; modernized plant for quality enhancement and international compliance.

Where we operate

Primarily India with growing exports overseas including global microbiology markets.

Top products or what we offer

Biological peptones, extracts, dehydrated culture media, sterile ready-made media, lab chemicals, and amino acid chelates.

Top brands

-

Raw materials needed

Animal tissues like meat, liver, brain, blood; vegetable products such as soy and casein.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue is largely recurring through steady demand from pharma and research sectors.

Our industry position

Established Indian player with international quality recognition and expanding export footprint.

Financial highlights

FY 2024-25 revenue Rs.156.45 Cr; profit Rs.21.53 Cr; consolidated total income Rs.160.36 Cr with stable EBITDA ~21.7%.

Geographical revenue split

Approximately 66% domestic and 34% overseas revenue in FY 2024-25.

Order book

-

Whats driving growth

Product innovation, plant modernization, international marketing, and rising demand in pharma and research sectors.

Our future plans

Expand international markets, develop health supplements, increase marketing via exhibitions and digital channels.

Our green promise

Supports green initiatives like electronic communications; ongoing compliance with environmental standards.

Our people and values

Boards with experience mix; emphasis on corporate governance and workplace safety including policies on harassment.

Key challenges ahead

Managing raw material supply, regulatory changes, and maintaining competitive edge globally.

Interesting facts

One of few Indian manufacturers offering gamma radiation sterilized culture media and harmonized formulations.

Risks and strategy

Mitigates risks through plant modernization, robust compliance, and diversification of product portfolio and markets.

Market Footprint

Top Clients

Top Clients

Pharmaceutical companies, clinical labs, research institutes, universities, food and water safety labs; B2B focus.

Top Products

Top Products

Biological peptones, extracts, dehydrated culture media, sterile ready-made media, lab chemicals, and amino acid chelates.

Price Movement & Share Holding

Today's High/Low

346365

52 Week High/Low

137.12444.52
Past Returns

1 week

-16.08%

1 month

-8.9%

3 month

-17.72%

1 year

57.14%

3 year

392.38%

5 year

487.55%

Share Holding

Promoters

55.78%

FII

0%

DII

0%

Retail

30.64%

Others

13.58%

Company Overview

Founded Year

-

Listed Year

-

Headquarter

New Delhi, India

MD/CEO

-

Website

https://titanbiotechltd.com

Price Movement & Share Holding

Today's High/Low

346365

52 Week High/Low

137.12444.52

Past Returns

1 week

-16.08%

1 month

-8.9%

3 month

-17.72%

1 year

57.14%

3 year

392.38%

5 year

487.55%

Share Holding

Promoters

55.78%

FII

0%

DII

0%

Retail

30.64%

Others

13.58%

Company Facts

What we do

Titan Biotech Ltd manufactures biological peptones, extracts, and dehydrated culture media supporting microbiological growth in pharmaceutical, clinical, and research sectors.

Market share

A reputed manufacturer catering to domestic and international markets with growing exports and modernization to meet global standards.

Problem solved

Provides essential culture media and biological products vital for microbiology research, vaccine production, antibiotic testing, and contamination control.

Top clients or who we serve

Pharmaceutical companies, clinical labs, research institutes, universities, food and water safety labs; B2B focus.

Our journey and innovations

Introduced gamma radiation culture media and lab chemicals; modernized plant for quality enhancement and international compliance.

Where we operate

Primarily India with growing exports overseas including global microbiology markets.

Top products or what we offer

Biological peptones, extracts, dehydrated culture media, sterile ready-made media, lab chemicals, and amino acid chelates.

Raw materials needed

Animal tissues like meat, liver, brain, blood; vegetable products such as soy and casein.

Recurring vs cyclical contribution

Revenue is largely recurring through steady demand from pharma and research sectors.

Our industry position

Established Indian player with international quality recognition and expanding export footprint.

Financial highlights

FY 2024-25 revenue Rs.156.45 Cr; profit Rs.21.53 Cr; consolidated total income Rs.160.36 Cr with stable EBITDA ~21.7%.

Geographical revenue split

Approximately 66% domestic and 34% overseas revenue in FY 2024-25.

Whats driving growth

Product innovation, plant modernization, international marketing, and rising demand in pharma and research sectors.

Our future plans

Expand international markets, develop health supplements, increase marketing via exhibitions and digital channels.

Our green promise

Supports green initiatives like electronic communications; ongoing compliance with environmental standards.

Our people and values

Boards with experience mix; emphasis on corporate governance and workplace safety including policies on harassment.

Key challenges ahead

Managing raw material supply, regulatory changes, and maintaining competitive edge globally.

Interesting facts

One of few Indian manufacturers offering gamma radiation sterilized culture media and harmonized formulations.

Risks and strategy

Mitigates risks through plant modernization, robust compliance, and diversification of product portfolio and markets.

Market Footprint

Top Clients

Top Clients

Pharmaceutical companies, clinical labs, research institutes, universities, food and water safety labs; B2B focus.

Top Products

Top Products

Biological peptones, extracts, dehydrated culture media, sterile ready-made media, lab chemicals, and amino acid chelates.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions